Clinical Trials Browser

Triple Negative Breast Neoplasms × Mifepristone × Clear all

NCT03225547 2025-12-23

Study of Pembrolizumab and Mifepristone in Patients With Advanced HER2-negative Breast Cancer

Phase 2 Terminated

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT02788981 2025-06-10

Abraxane® With or Without Mifepristone for Advanced, Glucocorticoid Receptor-Positive, Triple-Negative Breast Cancer

Phase 2 Active not recruiting

29 enrolled 11 charts

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT05062174 2022-12-15

Breast Cancer BRCA1 Carriers: a Pilot Study

Bulbo-Spinal Atrophy, X-Linked, Triple Negative Breast Neoplasms